1. Home
  2. TRVI vs METC Comparison

TRVI vs METC Comparison

Compare TRVI & METC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRVI
  • METC
  • Stock Information
  • Founded
  • TRVI 2011
  • METC 2015
  • Country
  • TRVI United States
  • METC United States
  • Employees
  • TRVI N/A
  • METC N/A
  • Industry
  • TRVI Biotechnology: Pharmaceutical Preparations
  • METC Coal Mining
  • Sector
  • TRVI Health Care
  • METC Energy
  • Exchange
  • TRVI Nasdaq
  • METC Nasdaq
  • Market Cap
  • TRVI 383.4M
  • METC 369.4M
  • IPO Year
  • TRVI 2019
  • METC 2017
  • Fundamental
  • Price
  • TRVI $6.07
  • METC $9.87
  • Analyst Decision
  • TRVI Strong Buy
  • METC Strong Buy
  • Analyst Count
  • TRVI 8
  • METC 3
  • Target Price
  • TRVI $17.56
  • METC $15.67
  • AVG Volume (30 Days)
  • TRVI 1.6M
  • METC 995.3K
  • Earning Date
  • TRVI 05-06-2025
  • METC 05-07-2025
  • Dividend Yield
  • TRVI N/A
  • METC 4.88%
  • EPS Growth
  • TRVI N/A
  • METC N/A
  • EPS
  • TRVI N/A
  • METC 0.21
  • Revenue
  • TRVI N/A
  • METC $666,295,000.00
  • Revenue This Year
  • TRVI N/A
  • METC $12.66
  • Revenue Next Year
  • TRVI N/A
  • METC $17.56
  • P/E Ratio
  • TRVI N/A
  • METC $47.31
  • Revenue Growth
  • TRVI N/A
  • METC N/A
  • 52 Week Low
  • TRVI $2.30
  • METC $6.30
  • 52 Week High
  • TRVI $7.39
  • METC $16.22
  • Technical
  • Relative Strength Index (RSI)
  • TRVI 54.54
  • METC 60.89
  • Support Level
  • TRVI $4.85
  • METC $6.30
  • Resistance Level
  • TRVI $6.15
  • METC $8.40
  • Average True Range (ATR)
  • TRVI 0.50
  • METC 0.76
  • MACD
  • TRVI -0.04
  • METC 0.26
  • Stochastic Oscillator
  • TRVI 73.94
  • METC 93.70

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

About METC Ramaco Resources Inc.

Ramaco Resources Inc is a United States-based company that operates as a pure-play metallurgical coal company with operations in southern West Virginia and southwestern Virginia. Its portfolio includes high-quality metallurgical coal reserves & resources, with a focus on properties such as Elk Creek, Berwind, Knox Creek, and Maben. These properties are strategically located to serve North American blast furnace steel mills and coke plants, as well as international metallurgical coal consumers. Additionally, the company controls mineral deposits in Sheridan, Wyoming, exploring potential opportunities in rare earth elements and coal-to-carbon-based products. Operations are concentrated in the Appalachian basin, with active mines at Elk Creek, Berwind, Knox Creek, and Maben mining complexes.

Share on Social Networks: